Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

WNT10A mutations often cause ectodermal dysplasias, with males showing more tooth issues than females.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Lower SHBG levels may increase the risk of PCOS.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

SHBG may be a useful early indicator and treatment target for PCOS.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Hormones and genes affect hair growth and male baldness.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Dogs with sex hormone imbalances may not drink or pee a lot but often lose hair on their body and can have reproductive system issues.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

Finasteride causes harmful organ changes in female mice.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.